Research of Werner Syndrome has been linked to Premature Aging Syndrome, Malignant Neoplasms, Progeria, Neoplasms, Genomic Instability. The study of Werner Syndrome has been mentioned in research publications which can be found using our bioinformatics tool below. Researched pathways related to Werner Syndrome include Aging, Senescence, Dna Repair, Dna Replication, Cell Cycle. These pathways complement our catalog of research reagents for the study of Werner Syndrome including antibodies and ELISA kits against WRN, BLM, ELN, RECQL, INS.
Werner Syndrome Bioinformatics Tool
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Werner Syndrome below!
For more information on how to use Laverne, please read the How to Guide.
We have 2149 products for the study of Werner Syndrome that can be applied to Flow Cytometry, Chromatin Immunoprecipitation, Western Blot, Immunocytochemistry/Immunofluorescence, Immunohistochemistry, Chromatin Immunoprecipitation (ChIP) from our catalog of antibodies and ELISA kits.
Werner Syndrome is also known as werner syndrome, werner syndrome (disorder), werner's syndrome, adult progeria, ws, adult premature ageing syndrome, adult premature aging syndrome, coronary arteriosclerosis, coronary artery disease, wrn.
PRODUCT AVAILABILITY: Update Regarding the Evolving COVID-19 Situation
Bio-Techne appreciates the critical role that you and our products and services play in research efforts to further scientific innovation and discovery. We are continually assessing our manufacturing and supplier capabilities during the COVID-19 situation and are implementing precautionary measures to ensure uninterrupted supply of products and services. Currently, and as we abide by local shelter in place orders across the world, we are fully operational and do not anticipate any material supply disruptions across our Bio-Techne brands and product lines. As the situation evolves, our goal is to utilize preventive measures to reduce the threat that COVID-19 poses to our ability to meet the needs of our customers globally.